Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)

Michal Sieniawski, Thorsten Reineke, Lucia Nogova, Andreas Josting, Beate Pfistner, Volker Diehl, Andreas Engert

Blood (2008) 111 (1): 71–76.

https://doi.org/10.1182/blood-2007-02-073544

Published: 2008

Includes: Supplemental data

Journal Articles

Female Gonadal Toxicities after Treatment of Primary Hodgkin Lymphoma (HL). Analysis of the LENT-SOMA Questionnaire Registered in the Database of the German Hodgkin Study Group (GHSG).

Karolin Behringer, MD, Elena Gilman, Peter Borchmann, MD, Eva Heuser, MD, Beate Pfistner, Volker Diehl, MD, Andreas Engert, MD

Blood (2006) 108 (11): 4595.

https://doi.org/10.1182/blood.V108.11.4595.4595

Published: 2006

Journal Articles

HD12 Randomised Trial Comparing 8 Dose-Escalated Cycles of BEACOPP with 4 Escalated and 4 Baseline Cycles in Patients with Advanced Stage Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Lymphoma Study Group (GHSG), University of Cologne, D-50924 Cologne, Germany.

Andreas Engert, Jeremy Franklin, Rolf-Peter Mueller, Hans-Theodor Eich, Axel Gossmann, Hans Konrad Mueller-Hermelink, Thomas Cerny, Jana Markova, Anthony D. Ho, Lothar Kanz, Richard Greil, Wolfgang Hiddemann, Beate Pfistner, Volker Diehl

Blood (2006) 108 (11): 99.

https://doi.org/10.1182/blood.V108.11.99.99

Published: 2006

Journal Articles

Identification of Prognostic Factors in Early Unfavorable Stage Hodgkin’s Lymphoma (HL): An Individual Patient Data Meta-Analysis.

Julia Bohlius, Heinz Haverkamp, Volker Diehl, Houchingue Eghbali, Christopher Ferme, Jeremy Franklin, Beate Pfistner, Petra Schiller, John Raemaekers, Andreas Engert, Michel Henry-Amar

Blood (2006) 108 (11): 2473.

https://doi.org/10.1182/blood.V108.11.2473.2473

Published: 2006

Journal Articles

Identification of Prognostic Factors in Patients with Early Stage Unfavorable Hodgkin’s Lymphoma: An Individual Patient Data Meta-Analysis.

Julia Bohlius, MD, MScPH, Heinz Haverkamp, MSc, Volker Diehl, MD, Houchingue Eghbali, MD, Jeremy Franklin, MSc, Beate Pfistner, MSc, John Raemaekers, MD, PhD, Andreas Engert, MD, Michel Henry-Amar, MD, PhD

Blood (2005) 106 (11): 5577.

https://doi.org/10.1182/blood.V106.11.5577.5577

Published: 2005

Journal Articles

Mortality during Treatment of Patients with Advanced Hodgkin’s Lymphoma Undergoing Dose Escalated BEACOPP Chemotherapy: An Analysis of the German Hodgkin Study Group (GHSG).

Michael Fuchs, Jeremy Franklin, Beate Klimm, Andreas Josting, Beate Pfistner, Andreas Engert, Volker Diehl

Blood (2005) 106 (11): 2668.

https://doi.org/10.1182/blood.V106.11.2668.2668

Published: 2005

Journal Articles

Leucopenia during Treatment Is a Good Prognostic Risk Factor for Patients Undergoing Chemotherapy for Hodgkin’s Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG).

Beate Klimm, Thorsten Reineke, Heinz Haverkamp, Hans T. Eich, Karolin Behringer, Andreas Josting, Beate Pfistner, Volker Diehl, Andreas Engert

Blood (2005) 106 (11): 2674.

https://doi.org/10.1182/blood.V106.11.2674.2674

Published: 2005

Journal Articles

A Comparison of Outcome and Second Malignancies in Adolescents and Adult Patients with Hodgkin’s Lymphoma (HL). Results from the German Hodgkin Study Group.

Henning Bredenfeld, MD, Elena Gilman, Beate Pfistner, Volker Diehl, MD, Andreas Engert, MD.

Blood (2005) 106 (11): 2670.

https://doi.org/10.1182/blood.V106.11.2670.2670

Published: 2005

Journal Articles

Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG).

Andreas Engert, Annette Pluetschow, Hans T. Eich, Richard Herrmann, Bernd Doerken, Lothar Kanz, Richard Greil, Jana Markova, Beate Pfistner, Andreas Josting, Konrad Mueller-Hermelink, Ralf P. Mueller, Volker Diehl

Blood (2005) 106 (11): 2673.

https://doi.org/10.1182/blood.V106.11.2673.2673

Published: 2005

Journal Articles

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Bruce D. Cheson, MD, Beate Pfistner, PhD, Malik E. Juweid, MD, Lena Specht, MD, PhD, Steven T. Rosen, MD, Randy Gascoyne, MD, Sigrid Stroobants, MD, PhD, Volker Diehl, MD

Blood (2005) 106 (11): 18.

https://doi.org/10.1182/blood.V106.11.18.18

Published: 2005

Journal Articles

Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.

Volker Diehl, Corinne Brillant, Andreas Engert, Ralf-Peter Mueller, Hans-Theodor Eich, Konrad Mueller-Hermelink, Richard Herrmann, Jana Markova, Anthony Ho, Wolfgang Hiddemann, Bernd Doerken, Richard Greil, Andreas Josting, Beate Pfistner

Blood (2005) 106 (11): 816.

https://doi.org/10.1182/blood.V106.11.816.816

Published: 2005

Journal Articles

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Andreas Josting, MD, Jeremy Franklin, PhD, Michal Sieniawski, MD, Beate Pfistner, PhD, Thomas Schober, Hildtrud Nisters-Backes, Andreas Engert, MD, Volker Diehl, MD

Blood (2005) 106 (11): 818.

https://doi.org/10.1182/blood.V106.11.818.818

Published: 2005

Journal Articles

Elderly Patients with Early-Unfavorable Stage Hodgkin’s Disease (HD) Have a Poorer Outcome When Treated with Combined Modality Treatment and Extended Field Radiotherapy (EF): A Retrospective Analysis of the German Hodgkin Study Group.

Andreas Engert, MD, Heinz Haverkamp, Hans T. Eich, MD, Andreas Josting, MD, Beate Pfistner, Volker Diehl

Blood (2004) 104 (11): 1305.

https://doi.org/10.1182/blood.V104.11.1305.1305

Published: 2004

Journal Articles

Hodgin’s Lymphoma in Elderly Patients: A Comprehensive Analysis of the German Hodgkin Lymphoma Study Group (GHSG).

Andreas Engert, MD, Veronika Ballova, MD, Heinz Haverkamp, Beate Pfistner, PhD, Volker Diehl, MD

Blood (2004) 104 (11): 1306.

https://doi.org/10.1182/blood.V104.11.1306.1306

Published: 2004

Journal Articles

Comparison of Patients (Pts) Characteristic and Treatment Outcomes in Lymphocyte-Predominant (LPHD) and Classical Hodgkin’s Disease (cHD): A Report from the German Hodgkin Lymphoma Study Group (GHSG).

Lucia Nogova, MD, Thorsten Reineke, Andreas Josting, MD, Karolin Behringer, MD, Beate Pfistner, PhD, Volker Diehl, MD, Andreas Engert, MD

Blood (2004) 104 (11): 1309.

https://doi.org/10.1182/blood.V104.11.1309.1309

Published: 2004

Journal Articles

The Superior Prognosis of Female Patients with Hodgkin’s Lymphoma Is Related to More Treatment-Induced Leucopenia and Warrants a More Individualized Therapy.

Beate Klimm, MD, Thorsten Reineke, Heinz Haverkamp, Hans T. Eich, MD, Andreas Josting, MD, Beate Pfistner, PhD, Volker Diehl, MD, Andreas Engert, MD

Blood (2004) 104 (11): 1313.

https://doi.org/10.1182/blood.V104.11.1313.1313

Published: 2004

Journal Articles

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma

Ludmila Boudová, Emina Torlakovic, Jan Delabie, Peter Reimer, Beate Pfistner, Sabine Wiedenmann, Volker Diehl, Hans-Konrad Müller-Hermelink, Thomas Rüdiger

Blood (2003) 102 (10): 3753–3758.

https://doi.org/10.1182/blood-2003-02-0626

Published: 2003

NARROW

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)

Female Gonadal Toxicities after Treatment of Primary Hodgkin Lymphoma (HL). Analysis of the LENT-SOMA Questionnaire Registered in the Database of the German Hodgkin Study Group (GHSG).

HD12 Randomised Trial Comparing 8 Dose-Escalated Cycles of BEACOPP with 4 Escalated and 4 Baseline Cycles in Patients with Advanced Stage Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Lymphoma Study Group (GHSG), University of Cologne, D-50924 Cologne, Germany.

Identification of Prognostic Factors in Early Unfavorable Stage Hodgkin’s Lymphoma (HL): An Individual Patient Data Meta-Analysis.

Identification of Prognostic Factors in Patients with Early Stage Unfavorable Hodgkin’s Lymphoma: An Individual Patient Data Meta-Analysis.

Mortality during Treatment of Patients with Advanced Hodgkin’s Lymphoma Undergoing Dose Escalated BEACOPP Chemotherapy: An Analysis of the German Hodgkin Study Group (GHSG).

Leucopenia during Treatment Is a Good Prognostic Risk Factor for Patients Undergoing Chemotherapy for Hodgkin’s Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG).

A Comparison of Outcome and Second Malignancies in Adolescents and Adult Patients with Hodgkin’s Lymphoma (HL). Results from the German Hodgkin Study Group.

Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG).

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.

Outcome of Patients Progressing or Relapsing after Primary Treatment with Two Cycles of Chemotherapy and Radiotherapy for Early Stage (Favorable) Hodgkin’s Disease.

Elderly Patients with Early-Unfavorable Stage Hodgkin’s Disease (HD) Have a Poorer Outcome When Treated with Combined Modality Treatment and Extended Field Radiotherapy (EF): A Retrospective Analysis of the German Hodgkin Study Group.

Hodgin’s Lymphoma in Elderly Patients: A Comprehensive Analysis of the German Hodgkin Lymphoma Study Group (GHSG).

Comparison of Patients (Pts) Characteristic and Treatment Outcomes in Lymphocyte-Predominant (LPHD) and Classical Hodgkin’s Disease (cHD): A Report from the German Hodgkin Lymphoma Study Group (GHSG).

The Superior Prognosis of Female Patients with Hodgkin’s Lymphoma Is Related to More Treatment-Induced Leucopenia and Warrants a More Individualized Therapy.

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only